Articles
| Open Access |
DOI: Clinical And Functional Effectiveness Of Endonasal Electrophoresis In Combination With Electrostimulation In Complex Therapy Of Glaucomatous Optic Neuropathy
Temur Saidov , Head Of The Department Of Ophthalmology, Faculty Of Postgraduate Education Samarkand State Medical Institute, Uzbekistan Nodira Yangieva , PhD, Associate Professor Department Of Ophthalmology With The Course Of Gynecology, Tashkent State Dental Institute, Uzbekistan Firdavs Khamidullaev , Assistant Of The Course Of Ophthalmology, Faculty Of Postgraduate Education Samarkand State Medical Institute, Samarkand Eye Care Hospital, Uzbekistan Janna Nazarova , Associate Professor, Department Of Neurology Tashkent Institute Of Postgraduate Medical Education, Uzbekistan Okhun Nizomov , 1st Year Master's Of The Department Of Ophthalmology Samarkand State Medical Institute, UzbekistanAbstract
The aim of the study was the clinical and functional assessment of the complex treatment of glaucomatous optic neuropathy with the administration of the drug tanakan in the form of endonasal electrophoresis in combination with electrical stimulation according to IST and ultrasound Doppler mapping. We examined 43 (74 eyes) patients with GON aged from 58 to 76 years. The results of the study showed that this method effectively delays the development of optic nerve atrophy and, along with the improvement of visual functions, lengthens the positive effect of the main treatment, which was confirmed by a significant improvement in hemodynamic parameters according to the ultrasound Doppler study.
Keywords
Glaucoma optic neuropathy, retinoprotection, endonasal electrophoresis, electrical stimulation
References
Libman E.S., Kaleeva E.V. The state and dynamics of disability due to visual impairment in Russia, Congress of ophthalmologists of Russia, 9th: abstracts. Report Moscow:, 2010.
Flammer D. Glaucoma // Glaucoma. World Wide Printing, 2003, ― P.345
Kurysheva N.I. Glaucoma optic neuropathy, - Moscow: MED press-inform, 2006. – P.136.
Alekseev V.N., Kozlova N.V. The use of Retinalamin in patients with primary open-angle glaucoma // Glaucoma. 2013. №1, P. 49-52.
Neroev V.V., Erichev V.P., Lovpache D.N. Peptides in neuroprotective therapy of patients with primary open-angle glaucoma with normal ophthalmotonus // Retinalamin. Neuroprotection in ophthalmology.2012. №6. P.37.
Basinsky S.P., Basinsky A.S. The effectiveness of complex therapy of patients with primary unstabilized open-angle glaucoma with “normalized” ophthalmotonus // Clinical Ophthalmology. - 2015. – Тashkent: 6, №2. - P.62-64
Zakharov V.V., Yakhno N.N. The use of Tanakan in violation of cerebral and peripheral circulation // Russ. Medic, jurnal. – 2011. – Tashkent:.9 – P.6–8.
The effectiveness of percutaneous electrical stimulation in the treatment of patients with primary open-angle glaucoma / T.G. Kamenskikh, E.V. Veselova, Yu.A. Dubina // Modern technologies of the XXI century: Sat. scientific tr. - Saratov, 2009. – P. 53-54.
The effectiveness of percutaneous electrical stimulation in the treatment of patients with primary open-angle glaucoma / T.G. Kamenskikh, E.V. Veselova, Yu.A. Dubina // Russian National Forum. Sat. scientific tr. – Moscow:, 2008. – P. 487-489
Choplin N.T., Lundy D. C. Atlas of glaucoma, second edition. 2007.
Doshi V., Ying L.M., Azen S.P., Varma R. Sociodemographic, family history, and lifestyle risk factors for open-angle glaucoma and ocular hypertension. Ophthalmology, 2008; 115(1):639–647
Hara Y., Torlu N. Clinical potential of lamerzine, a Ca 2+ channel blocker as an antiglaucoma drug: effects on ocular circulation and retinal neuronal damage // Cardiovascular Drug Reviews. - 2014. - Vol. 22. - P. 199-214.
Lugasi A. Additional information to the in vitro antioxidant activity of Ginkgo biloba // L. hytother Res. - Vol. 13. - P. 160-162.
Quaranta L., Betelli S., Uva M. Effect of Ginkgo bilobaextract on preexisting visual field damage in normal tension glaucoma // Ophthalmology. - 2013. - Vol. 110. - P.359-362
Brian Chua, Ivan Goldberg. Neuroprotective agents in glaucoma therapy: Recent developments and future directions// Rev. Ophthalmol.- 2016.-v.5(5).-p.627-636.
Nazarova, J. (2021). Respiratory Disorders during Sleep with Chronic Obstructive Pulmonary Disease. International Journal Of Medical Science And Clinical Research Studies, 1(1), 18-23.
Nazarova, J. (2021). Features of Cognitive Status in Patients with Venous Cerebral Dysfunction on the Background of Chronic Cerebral Ischemia. Annals of the Romanian Society for Cell Biology, 4553-4557.
Nazarova, J. (2021). Estimation of Clinical and Neurophysiological State of Cognitive Functions during Epilepsy in the Background of Anti-Consumer Therapy. International Journal Of Medical Science And Clinical Research Studies, 1(1), 01-04.
Nazarova, J. (2021). Features of Cognitive Disorders in Adults Epilepsy. International Journal Of Medical Science And Clinical Research Studies, 1(1), 09-13.
Article Statistics
Copyright License
Copyright (c) 2021 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.